APO Research
Talk to an analyst

APO RESEARCH · REPORT

Full Blood Count (FBC) Test

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Full Blood Count (FBC) Test Market Analysis and Forecast 2026-2032

2 May 2026201 pages

Choose your research edition.

Industry ResearchFull Blood Count (FBC) Test Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Full Blood Count (FBC) Test Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Full Blood Count (FBC) Test Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Full Blood Count (FBC) Test Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Full Blood Count (FBC) Test Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Full Blood Count (FBC) Test market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Full Blood Count (FBC) Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Full Blood Count (FBC) Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Full Blood Count (FBC) Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Full Blood Count (FBC) Test is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Full Blood Count (FBC) Test include one day tests, Labcorp OnDemand, Quest, Diag, Personalabs, Blue Horizo​​n, Metropolis Healthcare, Hila and LabFinder, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Full Blood Count (FBC) Test, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Full Blood Count (FBC) Test, also provides the revenue of main regions and countries. Of the upcoming market potential for Full Blood Count (FBC) Test, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Full Blood Count (FBC) Test revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Full Blood Count (FBC) Test market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Full Blood Count (FBC) Test revenue, projected growth trends, production technology, application and end-user industry.

Full Blood Count (FBC) Test Segment by Company

one day tests

Labcorp OnDemand

Quest

Diag

Personalabs

Blue Horizo​​n

Metropolis Healthcare

Hila

LabFinder

MAYO CLINIC

Better2Know

Medichecks

Vitall

Lab Me

Welzo

Full Blood Count (FBC) Test Segment by Type

Fingerstick Blood

Venous Blood

Full Blood Count (FBC) Test Segment by Application

Domestic

Commercial

Full Blood Count (FBC) Test Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Full Blood Count (FBC) Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Full Blood Count (FBC) Test and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Full Blood Count (FBC) Test.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Full Blood Count (FBC) Test in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Full Blood Count (FBC) Test company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Full Blood Count (FBC) Test revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Full Blood Count (FBC) Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Fingerstick Blood Major Player Table 3. Venous Blood Major Player Table 4. Global Full Blood Count (FBC) Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Domestic Major Player Table 6. Commercial Major Player Table 7. Full Blood Count (FBC) Test Industry Trends Table 8. Full Blood Count (FBC) Test Industry Drivers Table 9. Full Blood Count (FBC) Test Industry Opportunities and Challenges Table 10. Full Blood Count (FBC) Test Industry Restraints Table 11. Global Full Blood Count (FBC) Test Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Full Blood Count (FBC) Test Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Full Blood Count (FBC) Test Market Share by Region (2021-2026) Table 14. Global Full Blood Count (FBC) Test Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Full Blood Count (FBC) Test Market Share by Region (2027-2032) Table 16. Global Full Blood Count (FBC) Test Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Full Blood Count (FBC) Test Revenue Market Share by Players (2021-2026) Table 18. Global Full Blood Count (FBC) Test Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Full Blood Count (FBC) Test Key Players Headquarters & Area Served Table 20. Global Full Blood Count (FBC) Test Players, Product Type & Application Table 21. Global Full Blood Count (FBC) Test Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Full Blood Count (FBC) Test by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Full Blood Count (FBC) Test Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Full Blood Count (FBC) Test Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Full Blood Count (FBC) Test Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Full Blood Count (FBC) Test Revenue Market Share by Type (2021-2026) Table 28. Global Full Blood Count (FBC) Test Revenue Market Share by Type (2027-2032) Table 29. Global Full Blood Count (FBC) Test Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Full Blood Count (FBC) Test Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Full Blood Count (FBC) Test Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Full Blood Count (FBC) Test Revenue Market Share by Application (2021-2026) Table 33. Global Full Blood Count (FBC) Test Revenue Market Share by Application (2027-2032) Table 34. one day tests Company Information Table 35. one day tests Business Overview Table 36. one day tests Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. one day tests Full Blood Count (FBC) Test Product Portfolio Table 38. one day tests Recent Development Table 39. Labcorp OnDemand Company Information Table 40. Labcorp OnDemand Business Overview Table 41. Labcorp OnDemand Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Labcorp OnDemand Full Blood Count (FBC) Test Product Portfolio Table 43. Labcorp OnDemand Recent Development Table 44. Quest Company Information Table 45. Quest Business Overview Table 46. Quest Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Quest Full Blood Count (FBC) Test Product Portfolio Table 48. Quest Recent Development Table 49. Diag Company Information Table 50. Diag Business Overview Table 51. Diag Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Diag Full Blood Count (FBC) Test Product Portfolio Table 53. Diag Recent Development Table 54. Personalabs Company Information Table 55. Personalabs Business Overview Table 56. Personalabs Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Personalabs Full Blood Count (FBC) Test Product Portfolio Table 58. Personalabs Recent Development Table 59. Blue Horizo​​n Company Information Table 60. Blue Horizo​​n Business Overview Table 61. Blue Horizo​​n Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Blue Horizo​​n Full Blood Count (FBC) Test Product Portfolio Table 63. Blue Horizo​​n Recent Development Table 64. Metropolis Healthcare Company Information Table 65. Metropolis Healthcare Business Overview Table 66. Metropolis Healthcare Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Metropolis Healthcare Full Blood Count (FBC) Test Product Portfolio Table 68. Metropolis Healthcare Recent Development Table 69. Hila Company Information Table 70. Hila Business Overview Table 71. Hila Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Hila Full Blood Count (FBC) Test Product Portfolio Table 73. Hila Recent Development Table 74. LabFinder Company Information Table 75. LabFinder Business Overview Table 76. LabFinder Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. LabFinder Full Blood Count (FBC) Test Product Portfolio Table 78. LabFinder Recent Development Table 79. MAYO CLINIC Company Information Table 80. MAYO CLINIC Business Overview Table 81. MAYO CLINIC Full Blood Count (FBC) Test Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. MAYO CLINIC Full Blood Count (FBC) Test Product Portfolio Table 83. MAYO CLINIC Recent Development Table 84. Better2Know Company Information Table 85. Better2Know Business Overview Table 86. Better2Know Full Blood Count (FBC) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Better2Know Full Blood Count (FBC) Test Product Portfolio Table 88. Better2Know Recent Development Table 89. Medichecks Company Information Table 90. Medichecks Business Overview Table 91. Medichecks Full Blood Count (FBC) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Medichecks Full Blood Count (FBC) Test Product Portfolio Table 93. Medichecks Recent Development Table 94. Vitall Company Information Table 95. Vitall Business Overview Table 96. Vitall Full Blood Count (FBC) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Vitall Full Blood Count (FBC) Test Product Portfolio Table 98. Vitall Recent Development Table 99. Lab Me Company Information Table 100. Lab Me Business Overview Table 101. Lab Me Full Blood Count (FBC) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Lab Me Full Blood Count (FBC) Test Product Portfolio Table 103. Lab Me Recent Development Table 104. Welzo Company Information Table 105. Welzo Business Overview Table 106. Welzo Full Blood Count (FBC) Test Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Welzo Full Blood Count (FBC) Test Product Portfolio Table 108. Welzo Recent Development Table 109. North America Full Blood Count (FBC) Test Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Full Blood Count (FBC) Test Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Full Blood Count (FBC) Test Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Full Blood Count (FBC) Test Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Full Blood Count (FBC) Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Full Blood Count (FBC) Test Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Full Blood Count (FBC) Test Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Full Blood Count (FBC) Test Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Full Blood Count (FBC) Test Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Full Blood Count (FBC) Test Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Full Blood Count (FBC) Test Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Full Blood Count (FBC) Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Full Blood Count (FBC) Test Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Full Blood Count (FBC) Test Revenue by Country (US$ Million) & (2027-2032) Table 123. China Full Blood Count (FBC) Test Revenue by Type (2021-2026) & (US$ Million) Table 124. China Full Blood Count (FBC) Test Revenue by Type (2027-2032) & (US$ Million) Table 125. China Full Blood Count (FBC) Test Revenue by Application (2021-2026) & (US$ Million) Table 126. China Full Blood Count (FBC) Test Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Full Blood Count (FBC) Test Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Full Blood Count (FBC) Test Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Full Blood Count (FBC) Test Revenue by Application (2021-2026) & (US$ Million) Table 130. Asia Full Blood Count (FBC) Test Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Full Blood Count (FBC) Test Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Full Blood Count (FBC) Test Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Full Blood Count (FBC) Test Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Full Blood Count (FBC) Test Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Full Blood Count (FBC) Test Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Full Blood Count (FBC) Test Revenue by Application (2021-2026) & (US$ Million) Table 137. SAMEA Full Blood Count (FBC) Test Revenue by Application (2027-2032) & (US$ Million) Table 138. SAMEA Full Blood Count (FBC) Test Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Full Blood Count (FBC) Test Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Full Blood Count (FBC) Test Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Full Blood Count (FBC) Test Image Figure 2. Global Full Blood Count (FBC) Test Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Full Blood Count (FBC) Test Market Size Share 2021 VS 2025 VS 2032 Figure 4. Fingerstick Blood Image Figure 5. Venous Blood Image Figure 6. Global Full Blood Count (FBC) Test Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Full Blood Count (FBC) Test Market Size Share 2021 VS 2025 VS 2032 Figure 8. Domestic Image Figure 9. Commercial Image Figure 10. Global Full Blood Count (FBC) Test Market Size (US$ Million) & (2021-2032) Figure 11. Global Full Blood Count (FBC) Test Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Full Blood Count (FBC) Test Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Full Blood Count (FBC) Test Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Full Blood Count (FBC) Test Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Full Blood Count (FBC) Test Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Full Blood Count (FBC) Test Revenue Market Share by Type (2021-2032) Figure 18. Global Full Blood Count (FBC) Test Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Full Blood Count (FBC) Test Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Full Blood Count (FBC) Test Revenue Market Share by Application (2021-2032) Figure 21. North America Full Blood Count (FBC) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Full Blood Count (FBC) Test Revenue Share by Type (2021-2032) Figure 23. North America Full Blood Count (FBC) Test Revenue Share by Application (2021-2032) Figure 24. North America Full Blood Count (FBC) Test Revenue Share by Country (2021-2032) Figure 25. United States Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Full Blood Count (FBC) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Full Blood Count (FBC) Test Revenue Share by Type (2021-2032) Figure 30. Europe Full Blood Count (FBC) Test Revenue Share by Application (2021-2032) Figure 31. Europe Full Blood Count (FBC) Test Revenue Share by Country (2021-2032) Figure 32. Germany Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Full Blood Count (FBC) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Full Blood Count (FBC) Test Revenue Share by Type (2021-2032) Figure 42. China Full Blood Count (FBC) Test Revenue Share by Application (2021-2032) Figure 43. Asia Full Blood Count (FBC) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Full Blood Count (FBC) Test Revenue Share by Type (2021-2032) Figure 45. Asia Full Blood Count (FBC) Test Revenue Share by Application (2021-2032) Figure 46. Asia Full Blood Count (FBC) Test Revenue Share by Region (2021-2032) Figure 47. Japan Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Full Blood Count (FBC) Test Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Full Blood Count (FBC) Test Revenue Share by Type (2021-2032) Figure 55. SAMEA Full Blood Count (FBC) Test Revenue Share by Application (2021-2032) Figure 56. SAMEA Full Blood Count (FBC) Test Revenue Share by Country (2021-2032) Figure 57. Brazil Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Full Blood Count (FBC) Test Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Fingerstick Blood
  • Venous Blood
Applications
  • Domestic
  • Commercial
Companies covered
  • one day tests
  • Labcorp OnDemand
  • Quest
  • Diag
  • Personalabs
  • Blue Horizo​​n
  • Metropolis Healthcare
  • Hila
  • LabFinder
  • MAYO CLINIC
  • Better2Know
  • Medichecks
  • Vitall
  • Lab Me
  • Welzo

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Full Blood Count (FBC) Test Market by Type
  3. 1.2.1 Global Full Blood Count (FBC) Test Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Fingerstick Blood
  5. 1.2.3 Venous Blood
  6. 1.3 Full Blood Count (FBC) Test Market by Application
  7. 1.3.1 Global Full Blood Count (FBC) Test Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Domestic
  9. 1.3.3 Commercial
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Full Blood Count (FBC) Test Market Dynamics
  1. 2.1 Full Blood Count (FBC) Test Industry Trends
  2. 2.2 Full Blood Count (FBC) Test Industry Drivers
  3. 2.3 Full Blood Count (FBC) Test Industry Opportunities and Challenges
  4. 2.4 Full Blood Count (FBC) Test Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Full Blood Count (FBC) Test Market Perspective (2021-2032)
  2. 3.2 Global Full Blood Count (FBC) Test Growth Trends by Region
  3. 3.2.1 Global Full Blood Count (FBC) Test Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Full Blood Count (FBC) Test Market Size by Region (2021-2026)
  5. 3.2.3 Global Full Blood Count (FBC) Test Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Full Blood Count (FBC) Test Revenue by Players
  2. 4.1.1 Global Full Blood Count (FBC) Test Revenue by Players (2021-2026)
  3. 4.1.2 Global Full Blood Count (FBC) Test Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Full Blood Count (FBC) Test Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Full Blood Count (FBC) Test Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Full Blood Count (FBC) Test Key Players Headquarters & Area Served
  7. 4.4 Global Full Blood Count (FBC) Test Players, Product Type & Application
  8. 4.5 Global Full Blood Count (FBC) Test Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Full Blood Count (FBC) Test Market CR5 and HHI
  11. 4.6.3 2025 Full Blood Count (FBC) Test Tier 1, Tier 2, and Tier 3
5 Full Blood Count (FBC) Test Market Size by Type
  1. 5.1 Global Full Blood Count (FBC) Test Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Full Blood Count (FBC) Test Revenue by Type (2021-2032)
  3. 5.3 Global Full Blood Count (FBC) Test Revenue Market Share by Type (2021-2032)
6 Full Blood Count (FBC) Test Market Size by Application
  1. 6.1 Global Full Blood Count (FBC) Test Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Full Blood Count (FBC) Test Revenue by Application (2021-2032)
  3. 6.3 Global Full Blood Count (FBC) Test Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 one day tests
  2. 7.1.1 one day tests Company Information
  3. 7.1.2 one day tests Business Overview
  4. 7.1.3 one day tests Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  5. 7.1.4 one day tests Full Blood Count (FBC) Test Product Portfolio
  6. 7.1.5 one day tests Recent Developments
  7. 7.2 Labcorp OnDemand
  8. 7.2.1 Labcorp OnDemand Company Information
  9. 7.2.2 Labcorp OnDemand Business Overview
  10. 7.2.3 Labcorp OnDemand Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Labcorp OnDemand Full Blood Count (FBC) Test Product Portfolio
  12. 7.2.5 Labcorp OnDemand Recent Developments
  13. 7.3 Quest
  14. 7.3.1 Quest Company Information
  15. 7.3.2 Quest Business Overview
  16. 7.3.3 Quest Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Quest Full Blood Count (FBC) Test Product Portfolio
  18. 7.3.5 Quest Recent Developments
  19. 7.4 Diag
  20. 7.4.1 Diag Company Information
  21. 7.4.2 Diag Business Overview
  22. 7.4.3 Diag Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Diag Full Blood Count (FBC) Test Product Portfolio
  24. 7.4.5 Diag Recent Developments
  25. 7.5 Personalabs
  26. 7.5.1 Personalabs Company Information
  27. 7.5.2 Personalabs Business Overview
  28. 7.5.3 Personalabs Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Personalabs Full Blood Count (FBC) Test Product Portfolio
  30. 7.5.5 Personalabs Recent Developments
  31. 7.6 Blue Horizo​​n
  32. 7.6.1 Blue Horizo​​n Company Information
  33. 7.6.2 Blue Horizo​​n Business Overview
  34. 7.6.3 Blue Horizo​​n Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Blue Horizo​​n Full Blood Count (FBC) Test Product Portfolio
  36. 7.6.5 Blue Horizo​​n Recent Developments
  37. 7.7 Metropolis Healthcare
  38. 7.7.1 Metropolis Healthcare Company Information
  39. 7.7.2 Metropolis Healthcare Business Overview
  40. 7.7.3 Metropolis Healthcare Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Metropolis Healthcare Full Blood Count (FBC) Test Product Portfolio
  42. 7.7.5 Metropolis Healthcare Recent Developments
  43. 7.8 Hila
  44. 7.8.1 Hila Company Information
  45. 7.8.2 Hila Business Overview
  46. 7.8.3 Hila Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Hila Full Blood Count (FBC) Test Product Portfolio
  48. 7.8.5 Hila Recent Developments
  49. 7.9 LabFinder
  50. 7.9.1 LabFinder Company Information
  51. 7.9.2 LabFinder Business Overview
  52. 7.9.3 LabFinder Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  53. 7.9.4 LabFinder Full Blood Count (FBC) Test Product Portfolio
  54. 7.9.5 LabFinder Recent Developments
  55. 7.10 MAYO CLINIC
  56. 7.10.1 MAYO CLINIC Company Information
  57. 7.10.2 MAYO CLINIC Business Overview
  58. 7.10.3 MAYO CLINIC Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  59. 7.10.4 MAYO CLINIC Full Blood Count (FBC) Test Product Portfolio
  60. 7.10.5 MAYO CLINIC Recent Developments
  61. 7.11 Better2Know
  62. 7.11.1 Better2Know Company Information
  63. 7.11.2 Better2Know Business Overview
  64. 7.11.3 Better2Know Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Better2Know Full Blood Count (FBC) Test Product Portfolio
  66. 7.11.5 Better2Know Recent Developments
  67. 7.12 Medichecks
  68. 7.12.1 Medichecks Company Information
  69. 7.12.2 Medichecks Business Overview
  70. 7.12.3 Medichecks Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Medichecks Full Blood Count (FBC) Test Product Portfolio
  72. 7.12.5 Medichecks Recent Developments
  73. 7.13 Vitall
  74. 7.13.1 Vitall Company Information
  75. 7.13.2 Vitall Business Overview
  76. 7.13.3 Vitall Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Vitall Full Blood Count (FBC) Test Product Portfolio
  78. 7.13.5 Vitall Recent Developments
  79. 7.14 Lab Me
  80. 7.14.1 Lab Me Company Information
  81. 7.14.2 Lab Me Business Overview
  82. 7.14.3 Lab Me Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Lab Me Full Blood Count (FBC) Test Product Portfolio
  84. 7.14.5 Lab Me Recent Developments
  85. 7.15 Welzo
  86. 7.15.1 Welzo Company Information
  87. 7.15.2 Welzo Business Overview
  88. 7.15.3 Welzo Full Blood Count (FBC) Test Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Welzo Full Blood Count (FBC) Test Product Portfolio
  90. 7.15.5 Welzo Recent Developments
8 North America
  1. 8.1 North America Full Blood Count (FBC) Test Revenue (2021-2032)
  2. 8.2 North America Full Blood Count (FBC) Test Revenue by Type (2021-2032)
  3. 8.2.1 North America Full Blood Count (FBC) Test Revenue by Type (2021-2026)
  4. 8.2.2 North America Full Blood Count (FBC) Test Revenue by Type (2027-2032)
  5. 8.3 North America Full Blood Count (FBC) Test Revenue Share by Type (2021-2032)
  6. 8.4 North America Full Blood Count (FBC) Test Revenue by Application (2021-2032)
  7. 8.4.1 North America Full Blood Count (FBC) Test Revenue by Application (2021-2026)
  8. 8.4.2 North America Full Blood Count (FBC) Test Revenue by Application (2027-2032)
  9. 8.5 North America Full Blood Count (FBC) Test Revenue Share by Application (2021-2032)
  10. 8.6 North America Full Blood Count (FBC) Test Revenue by Country
  11. 8.6.1 North America Full Blood Count (FBC) Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Full Blood Count (FBC) Test Revenue by Country (2021-2026)
  13. 8.6.3 North America Full Blood Count (FBC) Test Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Full Blood Count (FBC) Test Revenue (2021-2032)
  2. 9.2 Europe Full Blood Count (FBC) Test Revenue by Type (2021-2032)
  3. 9.2.1 Europe Full Blood Count (FBC) Test Revenue by Type (2021-2026)
  4. 9.2.2 Europe Full Blood Count (FBC) Test Revenue by Type (2027-2032)
  5. 9.3 Europe Full Blood Count (FBC) Test Revenue Share by Type (2021-2032)
  6. 9.4 Europe Full Blood Count (FBC) Test Revenue by Application (2021-2032)
  7. 9.4.1 Europe Full Blood Count (FBC) Test Revenue by Application (2021-2026)
  8. 9.4.2 Europe Full Blood Count (FBC) Test Revenue by Application (2027-2032)
  9. 9.5 Europe Full Blood Count (FBC) Test Revenue Share by Application (2021-2032)
  10. 9.6 Europe Full Blood Count (FBC) Test Revenue by Country
  11. 9.6.1 Europe Full Blood Count (FBC) Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Full Blood Count (FBC) Test Revenue by Country (2021-2026)
  13. 9.6.3 Europe Full Blood Count (FBC) Test Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Full Blood Count (FBC) Test Revenue (2021-2032)
  2. 10.2 China Full Blood Count (FBC) Test Revenue by Type (2021-2032)
  3. 10.2.1 China Full Blood Count (FBC) Test Revenue by Type (2021-2026)
  4. 10.2.2 China Full Blood Count (FBC) Test Revenue by Type (2027-2032)
  5. 10.3 China Full Blood Count (FBC) Test Revenue Share by Type (2021-2032)
  6. 10.4 China Full Blood Count (FBC) Test Revenue by Application (2021-2032)
  7. 10.4.1 China Full Blood Count (FBC) Test Revenue by Application (2021-2026)
  8. 10.4.2 China Full Blood Count (FBC) Test Revenue by Application (2027-2032)
  9. 10.5 China Full Blood Count (FBC) Test Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Full Blood Count (FBC) Test Revenue (2021-2032)
  2. 11.2 Asia Full Blood Count (FBC) Test Revenue by Type (2021-2032)
  3. 11.2.1 Asia Full Blood Count (FBC) Test Revenue by Type (2021-2026)
  4. 11.2.2 Asia Full Blood Count (FBC) Test Revenue by Type (2027-2032)
  5. 11.3 Asia Full Blood Count (FBC) Test Revenue Share by Type (2021-2032)
  6. 11.4 Asia Full Blood Count (FBC) Test Revenue by Application (2021-2032)
  7. 11.4.1 Asia Full Blood Count (FBC) Test Revenue by Application (2021-2026)
  8. 11.4.2 Asia Full Blood Count (FBC) Test Revenue by Application (2027-2032)
  9. 11.5 Asia Full Blood Count (FBC) Test Revenue Share by Application (2021-2032)
  10. 11.6 Asia Full Blood Count (FBC) Test Revenue by Country
  11. 11.6.1 Asia Full Blood Count (FBC) Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Full Blood Count (FBC) Test Revenue by Country (2021-2026)
  13. 11.6.3 Asia Full Blood Count (FBC) Test Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Full Blood Count (FBC) Test Revenue (2021-2032)
  2. 12.2 SAMEA Full Blood Count (FBC) Test Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Full Blood Count (FBC) Test Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Full Blood Count (FBC) Test Revenue by Type (2027-2032)
  5. 12.3 SAMEA Full Blood Count (FBC) Test Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Full Blood Count (FBC) Test Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Full Blood Count (FBC) Test Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Full Blood Count (FBC) Test Revenue by Application (2027-2032)
  9. 12.5 SAMEA Full Blood Count (FBC) Test Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Full Blood Count (FBC) Test Revenue by Country
  11. 12.6.1 SAMEA Full Blood Count (FBC) Test Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Full Blood Count (FBC) Test Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Full Blood Count (FBC) Test Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst